Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

44.4K
Overview
44.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: Wassilak et al. Impediments to Progress Toward Polio Eradication During 2014-2024: Effectively Addressing the Current Challenges. <i>Vaccines</i> 2025, <i>13</i>, 1060.

Vaccines·2025
Same author

Tracking poliovirus through wastewater: environmental surveillance insights from Haïti (2020-2023).

Applied and environmental microbiology·2025
Same author

Impediments to Progress Toward Polio Eradication During 2014-2024: Effectively Addressing the Current Challenges.

Vaccines·2025
Same author

It is not just about the training: rethinking strategies to strengthen the global emergency response workforce.

BMJ global health·2025
Same author

Understanding barriers to stool adequacy: results from a programmatic assessment of Pakistan's acute flaccid paralysis active surveillance system in 12 priority districts.

Frontiers in public health·2025
Same author

Feasibility of cohort event monitoring and assessment of reactogenicity and adverse events among a cohort of AstraZeneca and Moderna COVID-19 vaccine recipients in Nigeria, 2021.

Vaccine·2025
Same journal

QuickStats: Percentage of Births in Which Women Received Prenatal Care in the First Trimester of Pregnancy, by State - United States, 2024.

MMWR. Morbidity and mortality weekly report·2026
Same journal

Legionellosis Outbreaks Associated with Two Hotels - U.S. Virgin Islands, October 2024-April 2025.

MMWR. Morbidity and mortality weekly report·2026
Same journal

Alpha-gal Immunoglobulin E Seroprevalence Among Blood Donors - 10 States, 2024-2025.

MMWR. Morbidity and mortality weekly report·2026
Same journal

Notes from the Field: Drug Overdose Deaths in Hotels and Motels - United States, 2022-2024.

MMWR. Morbidity and mortality weekly report·2026
Same journal

Emergency Department Visits for Suspected Suicide Attempts - United States, 2021-2025.

MMWR. Morbidity and mortality weekly report·2026
Same journal

Notes from the Field: Initial Public Health Response to a Measles Outbreak in a Close-Knit West Texas Community - January-February 2025.

MMWR. Morbidity and mortality weekly report·2026
See all related articles

Related Experiment Video

Updated: Jun 26, 2025

Particle Agglutination Method for Poliovirus Identification
07:06

Particle Agglutination Method for Poliovirus Identification

Published on: April 20, 2011

15.3K

Progress Toward Poliomyelitis Eradication - Worldwide, January 2022-December 2023.

Keri Geiger, Tasha Stehling-Ariza, John Paul Bigouette

    MMWR. Morbidity and Mortality Weekly Report
    |May 16, 2024
    PubMed
    Summary
    This summary is machine-generated.

    Global polio eradication efforts continue, with wild poliovirus type 1 (WPV1) cases decreasing but spreading geographically. Circulating vaccine-derived poliovirus (cVDPV) outbreaks also increased, necessitating intensified vaccination and surveillance.

    More Related Videos

    Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen
    07:44

    Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

    Published on: May 12, 2023

    1.2K
    Remote Laboratory Management: Respiratory Virus Diagnostics
    14:56

    Remote Laboratory Management: Respiratory Virus Diagnostics

    Published on: April 6, 2019

    33.1K

    Related Experiment Videos

    Last Updated: Jun 26, 2025

    Particle Agglutination Method for Poliovirus Identification
    07:06

    Particle Agglutination Method for Poliovirus Identification

    Published on: April 20, 2011

    15.3K
    Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen
    07:44

    Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

    Published on: May 12, 2023

    1.2K
    Remote Laboratory Management: Respiratory Virus Diagnostics
    14:56

    Remote Laboratory Management: Respiratory Virus Diagnostics

    Published on: April 6, 2019

    33.1K

    Area of Science:

    • Public Health
    • Epidemiology
    • Infectious Disease Control

    Background:

    • Poliomyelitis (polio) eradication efforts began in 1988, successfully eliminating two wild poliovirus (WPV) serotypes.
    • Wild poliovirus type 1 (WPV1) remains endemic in Afghanistan and Pakistan, posing the primary challenge to global eradication.
    • Circulating vaccine-derived polioviruses (cVDPVs) represent a significant public health concern, arising from vaccine virus reversion.

    Purpose of the Study:

    • To report on global polio immunization and surveillance activities from January 2022 to December 2023.
    • To analyze the epidemiology of wild poliovirus type 1 (WPV1) and circulating vaccine-derived polioviruses (cVDPVs) during the reporting period.
    • To assess progress towards global polio eradication and identify areas requiring intensified intervention.

    Main Methods:

    • Analysis of global polio immunization and surveillance data, including case reporting and environmental surveillance.
    • Epidemiological assessment of wild poliovirus type 1 (WPV1) and circulating vaccine-derived poliovirus (cVDPV) transmission.
    • Data collection and reporting current as of April 10, 2024.

    Main Results:

    • Wild poliovirus type 1 (WPV1) cases decreased from 22 in 2022 to 12 in 2023 in Afghanistan and Pakistan.
    • WPV1 transmission detected in 13 provinces via environmental surveillance in 2023, up from seven in 2022.
    • Circulating vaccine-derived poliovirus (cVDPV) cases decreased from 881 in 2022 to 524 in 2023, but outbreaks occurred in 32 countries, including eight new ones.

    Conclusions:

    • Despite reductions in paralytic polio cases, both cVDPV and WPV1 cases were more geographically widespread in 2023.
    • Sustained progress requires renewed efforts in vaccinating persistently missed children in endemic areas.
    • Strengthening routine immunization and improving cVDPV outbreak responses are crucial for achieving global polio eradication.